Clindamycin Phosphate

Licensed by Pfizer Catalog No.S2048 Synonyms: NSC 618653

For research use only.

Clindamycin Phosphate (NSC 618653) is a lincosamide antibiotic for Plasmodium falciparum with IC50 of 12 nM.

Clindamycin Phosphate Chemical Structure

CAS No. 24729-96-2

Purity & Quality Control

Choose Selective Antibiotics Inhibitors

Biological Activity

Description Clindamycin Phosphate (NSC 618653) is a lincosamide antibiotic for Plasmodium falciparum with IC50 of 12 nM.

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 504.96
Formula

C18H34ClN2O8PS

CAS No. 24729-96-2
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05223400 Not yet recruiting Drug: Clindamycin Injection Infection Bacterial Alexandria University March 2022 --
NCT04946500 Active not recruiting -- Prosthetic Joint Infection|Staphylococcus University Hospital Brest May 15 2021 --
NCT04220918 Recruiting -- Medication Adherence|Medication Reaction Children''s Hospital of Philadelphia|National Institute on Deafness and Other Communication Disorders (NIDCD)|Monell Chemical Senses Center February 14 2020 --
NCT03845790 Recruiting Other: Blood and microdialysis samples Surgical Site Infection Poitiers University Hospital May 26 2019 Phase 1

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Clindamycin Phosphate | Clindamycin Phosphate ic50 | Clindamycin Phosphate price | Clindamycin Phosphate cost | Clindamycin Phosphate solubility dmso | Clindamycin Phosphate purchase | Clindamycin Phosphate manufacturer | Clindamycin Phosphate research buy | Clindamycin Phosphate order | Clindamycin Phosphate mouse | Clindamycin Phosphate chemical structure | Clindamycin Phosphate mw | Clindamycin Phosphate molecular weight | Clindamycin Phosphate datasheet | Clindamycin Phosphate supplier | Clindamycin Phosphate in vitro | Clindamycin Phosphate cell line | Clindamycin Phosphate concentration | Clindamycin Phosphate nmr